The Urology Austin Clinical Research Department is now recruiting for the following clinical trails. If you’re interested in participating and want to learn more about enrollment criteria, contact our research team for more information:
email: UA-Research@urologyaustin.com
phone: 512-410-3773
Thank you for your interest.
Actively Enrolling Trials
MagForce for Prostate Cancer
Urology Austin is excited to announce our participation in a new clinical trial for prostate cancer. The MagForce study is an emerging treatment option for prostate cancer that does not involve radiation or surgery. Candidates for this study must have Gleason 3+4 prostate cancer and cannot have been treated previously, except for active surveillance. Click the link below to learn more.
MagForce Trial Patient Brochure 2022
Benign Prostatic Hyperplasia (BPH or enlarged prostate)
Urology Austin is excited to announce the start of promising new clinical trials for men with an enlarged prostate (BPH.) These systems take a simple and intuitive approach to relieving the obstruction caused by BPH. They are performed as an outpatient, and they use no cutting, no energy, and they remove no tissue. We believe these exciting new studies may help launch a new era of BPH treatment options.
Click below for further information or to consider participation in these studies.
Butterfly Medical Trifold Brochure May 2022
CLIN-0192 Rev B BREEZE Subject Information Sheet_Urology Austin
Sacral Neuromodulation (SNM) for Urinary Leakage
Urology Austin is excited to announce that we are participating in the Neuspera clinical study . The Neuspera sacral neuromodulation (SNM) is an investigational device designed to reduce urinary leakage through a minimally-invasive, outpatient procedure. The Neuspera procedure uses a microimplant that is placed near the sacral nerve through a needle-like incision in the lower back. Once placed, the Neuspera implant delivers gentle, adjustable electrical stimulation to the sacral nerve to help calm the bladder.
If you are a male or female 22+ years of age and have a diagnosis of a OAB/Urinary Urge Incontinence (UUI), you may be eligible to participate.
Click the link below for further information on the trail. Please contact the research department if you feel you may be a good candidate for the study.
Previous Trials Closed to Enrollment
Kidney Stones
CM00001_A 7883_Calyxo_PatientRecruitmentBro_3.875x9_4 FINAL
Benign Prostatic Hyperplasia (BPH or enlarged prostate)
Recruiting Men for in-office BPH Research Treatment
• Participant must be ≥ 50 years old
• Diagnosis of symptomatic BPH
• Prostate volume 30cm3 ≤ 80cm3
• No previous BPH surgery
Compensation for time and some procedures
https://clinicaltrials.gov/ct2/show/NCT04338776
Bladder Cancer
- Recruiting Men & Women